5225 Results

People

  1. Giralt
    Giralt
  2. Hellmann
    Hellmann
  3. Ladanyi
    Ladanyi
  4. Motzer
    Motzer
  5. Lee
    Lee
  6. Arcila
    Arcila
  7. Berger
    Berger
  8. Hyman
    Hyman
  9. Drilon
    Drilon
  10. Levine
    Levine

Groups

  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)
  7. Survivorship Research (854)
  8. Hematologic Malignancies, Division of (789)
  9. Population Sciences Research Program (691)
  10. Department of Pathology and Laboratory Medicine (685)
  1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The RNA binding protein MSI2 has increased RNA binding activity in leukemic stem cells compared to normal hematopoietic stem cells
    Meeting Abstract

    Nguyen, D.; Lu, Y.; Choo, Z.; Chin, C.; Prieto, C.; Gourkanti, S.; Leslie, C.; Kharas, M. G.
    Blood (2018)

    Fulltext@MSK | Save
  • Dosing patterns of dasatinib use in simplicity, an observational study in chronic phase chronic myeloid leukemia (CP-CML) patients (pts) in routine clinical practice
    Meeting Abstract

    Cortes, J. E.; Chen, C.; Mauro, M. J.; Sen, G. P.; Gajavelli, S.; Davis, C.; Goldberg, S. L.
    Blood (2018)

    Fulltext@MSK | Save
  • ADCT-301 (camidanlumab tesirine), a novel pyrrolobenzodiaze-based CD25-targeting antibody drug conjugate, in a phase 1 study of replased/refractory non-Hodgkin lymphoma shows activity in T-cell lymphoma
    Meeting Abstract

    Collins, G. P.; Horwitz, S. M.; Davies, A.; Karnad, A.; Samaniego, F.; Spira, A. I.; Fields, P. A.; Menne, T.; Boni, J.; Cruz, H.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Early results from a biomarker-directed phase 2 trial of SY-1425 in combination with azacitidine or daratumumab in non-APL acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Cook, R. J.; Moyo, T.; Liesveld, J. L.; Rizzieri, D. A.; Stein, E. M.; De Botton, S.; Roboz, G. J.; Sekeres, M. A.; Jurcic, J. G.; Raza, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Incidence of post-hematopoietic stem cell transplantation (HSCT) veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) without hyperbilirubinemia at diagnosis and efficacy of defibrotide in an expanded-access program
    Meeting Abstract

    Corbacioglu, S.; Kernan, N. A.; Pagliuca, A.; Ryan, R.; Tappe, W.; Richardson, P.
    Blood (2018)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy in adolescents and young adults (AYA) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 ECHELON-1 study
    Meeting Abstract

    Crosswell, H. E.; LaCasce, A. S.; Bartlett, N. L.; Straus, D. J.; Savage, K. J.; Fenton, K.; Engley, G.; Jolin, H.; Liu, R.; Zinzani, P. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The lysine histone methyltransferase SETD2 is required for appropriate immunoglobulin VDJ recombination
    Meeting Abstract

    Chu, S. H. H.; Chabon, J.; Minehart, J.; Matovina, C. N.; Zhang, J.; Chen, B. R.; Callen-Moreu, E.; Hung, P. J.; Feng, Z.; Koche, R.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • m(6)A maintains hematopoietic stem and progenitor cell identity
    Meeting Abstract

    Cheng, Y.; Luo, H.; Izzo, F.; Pickering, B. F.; Vu, L. P.; Schurer, A.; Gourkanti, S.; Jaffrey, S. R.; Landau, D. A.; Kharas, M. G.
    Blood (2018)

    Fulltext@MSK | Save
  • PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
    Meeting Abstract

    Chen, Y. B.; Armand, P.; Redd, R. A.; Bsat, J.; Merryman, R. W.; Coleman, K.; Herrera, A. F.; Dahi, P. B.; Nieto, Y.; LaCasce, A. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Genomic and proteomic profiling of AF10-fusion oncoproteins reveal mechanisms of leukemogenesis and actionable targets
    Meeting Abstract

    Chen, B. R.; Deshpande, A.; Kleppe, M.; Yeddula, N.; Yoh, S.; Armstrong, S. A.; Levine, R. L.; Chanda, S.; Deshpande, A. J.
    Blood (2018)

    Fulltext@MSK | Save